Related Experiment Video
Updated: Apr 6, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Why Anticancer Nanomedicine Needs Sugars?
E Bouffard, K El Cheikh, A Gallud
1DR1 Inserm, Institut des Biomolecules Max Mousseron, UMR 5247 CNRS-UM, 15 Avenue Charles Flahault, BP 14491, 34093 Montpellier Cedex 05, France. marcel.garcia@inserm.fr.
Carbohydrate derivatives are increasingly used in nanomedicine to improve drug delivery and biocompatibility. These sugars enhance solubility, reduce clearance, mask immunogenic components, and facilitate targeted tissue delivery.
Area of Science:
- Nanomedicine
- Biomaterials Science
- Carbohydrate Chemistry
Background:
- Nanomedicine leverages nanoscale materials, biomolecules, and physicochemical processes for advanced diagnosis and treatment.
- Functionalizing nanomaterials with biomolecules is crucial for enhancing biocompatibility and therapeutic efficacy.
Purpose of the Study:
- To highlight the growing importance and applications of carbohydrate derivatives in nanomedicine.
- To explain how sugars are utilized to improve nanocarrier performance and therapeutic outcomes.
Main Methods:
- Review of current literature on carbohydrate functionalization in nanomedicine.
- Analysis of the roles of carbohydrates in enhancing nanocarrier properties.
Main Results:
- Carbohydrate derivatives are increasingly incorporated into nanostructures for medical applications.
- Sugars mimic physiological roles, improving solubility and reducing drug clearance.
- Carbohydrates aid in evading immune responses and facilitate targeted delivery to specific tissues.
Conclusions:
- The unique properties of carbohydrates make them valuable components in nanomedicine.
- Functionalization with sugars significantly enhances the efficacy and safety of nanomedicines.
More Related Videos
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drug toxicity: Drug–Drug Interaction
Treatment Resistant Cancers